$3.05
-0.08-2.56%
At Close: -
$3.04
-0.0100-0.33%
After Hours: 5:06 PM EDT
15 minutes delayed
Comments
Loading...
RAPT Therapeutics
RAPTNASDAQ
RAPT Therapeutics (NASDAQ:RAPT) Stock, Earnings Estimates, EPS, And Revenue
RAPT Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 9
EPS Estimate
$-0.720
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of RAPT Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RAPT | RAPT Therapeutics | -$0.66 | -$0.72 | — | — | $0.00 | — | — | — | 08/09/2024 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.76 | -$0.81 | -$0.79 | 2.47% | $0.00 | — | $0.00 | — | 05/09/2024 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.64 | -$0.86 | -$0.80 | 6.98% | $0.00 | — | $0.00 | — | 03/07/2024 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.63 | -$0.75 | -$0.82 | -9.33% | $0.00 | — | $0.00 | — | 11/13/2023 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.62 | -$0.80 | -$0.66 | 17.50% | $886.00K | — | $0.00 | — | 08/11/2023 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.69 | -$0.68 | -$0.76 | -11.76% | $641.00K | — | $0.00 | — | 05/11/2023 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.61 | -$0.66 | -$0.64 | 3.03% | $756.00K | $220.00K | $0.00 | -100.00% | 03/14/2023 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.63 | -$0.67 | -$0.63 | 5.97% | $966.00K | $340.00K | $0.00 | -100.00% | 11/10/2022 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.63 | -$0.75 | -$0.62 | 17.33% | $869.00K | $280.00K | $886.00K | 216.43% | 08/11/2022 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.66 | -$0.68 | -$0.69 | -1.47% | $1.22M | $220.00K | $641.00K | 191.36% | 05/11/2022 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.52 | -$0.66 | -$0.61 | 7.58% | $1.30M | $700.00K | $756.00K | 8.00% | 03/10/2022 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.60 | -$0.62 | -$0.63 | -1.61% | $1.53M | $780.00K | $966.00K | 23.85% | 11/10/2021 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.51 | -$0.67 | -$0.63 | 5.97% | $1.28M | $950.00K | $869.00K | -8.53% | 08/11/2021 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.56 | -$0.71 | -$0.66 | 7.04% | $0.00 | $870.00K | $1.22M | 40.46% | 05/11/2021 | Get Alert |
| RAPT | RAPT Therapeutics | -$0.87 | — | -$0.52 | — | $0.00 | — | $1.30M | — | 03/11/2021 | Get Alert |
| RAPT | RAPT Therapeutics | -$12.41 | — | -$0.60 | — | $0.00 | — | $1.53M | — | 11/16/2020 | Get Alert |
| RAPT | RAPT Therapeutics | — | — | -$0.51 | — | — | — | $1.28M | — | 08/13/2020 | Get Alert |
| RAPT | RAPT Therapeutics | -$13.28 | — | -$0.56 | — | — | — | $0.00 | — | 05/14/2020 | Get Alert |
| RAPT | RAPT Therapeutics | — | -$0.69 | -$0.87 | -26.09% | — | — | $0.00 | — | 03/30/2020 | Get Alert |
| RAPT | RAPT Therapeutics | -$15.90 | — | -$12.41 | — | — | — | $0.00 | — | 12/11/2019 | Get Alert |
RAPT Therapeutics (RAPT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $-0.79 | $-0.81 | 2.47 % |
| Dec 2023 | 2024-03-07 | $-0.80 | $-0.86 | 6.98 % |
| Sep 2023 | 2023-11-13 | $-0.82 | $-0.75 | -9.33 % |
| Jun 2023 | 2023-08-11 | $-0.66 | $-0.80 | 17.5 % |
RAPT Therapeutics (RAPT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Dec 2022 | 2023-03-14 | $0 | $220.00K | -100.0 % |
| Sep 2022 | 2022-11-10 | $0 | $340.00K | -100.0 % |
| Jun 2022 | 2022-08-11 | $886.00K | $280.00K | 216.4 % |
| Mar 2022 | 2022-05-11 | $641.00K | $220.00K | 191.4 % |
FAQ
When is RAPT Therapeutics (NASDAQ:RAPT) reporting earnings?
RAPT Therapeutics (RAPT) is scheduled to report earnings on August 9, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for RAPT Therapeutics (NASDAQ:RAPT)?
The Actual EPS was $-0.79, which beat the estimate of $-0.81.
What were RAPT Therapeutics’s (NASDAQ:RAPT) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.